Investment and M&A transaction comps
Consumer Investment & M&A Transaction Comps
Global consumer investments, capital raises and M&A transactions across CPG, food, beverage, beauty, personal care, wellness, pet and adjacent branded categories.
213
Reviewed transactions
149
With price data
4.1x
Median EV or valuation / revenue
16.3x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 12 | 9 | 4.0x | 9.9x |
| 2025 | 14 | 14 | 3.3x | 12.7x |
| 2024 | 12 | 11 | 3.6x | 16.0x |
| 2023 | 20 | 18 | 4.0x | 20.9x |
| 2022 | 20 | 10 | 4.9x | 20.4x |
| 2021 | 25 | 20 | 4.7x | 15.2x |
| 2020 | 15 | 10 | 4.2x | 14.7x |
| 2019 | 8 | 7 | 4.3x | 17.4x |
Sortable transaction comps
Consumer transaction table
Rows with reported value
19 / 25
Acquisition EV, USD
USD 45B
Investment EV, USD
USD 1.3B
Median EV / revenue
4.2x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 213 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| DECIEM Beauty Group Inc. Control (48%) | 2021-02-23 | The Estée Lauder Companies Inc. | USD 2.2B Enterprise Value | 2,200 | 4.8x | - | Canada | Confirmed 5 sources | ||
| GW Pharmaceuticals Control | 2021-02-03 | Jazz Pharmaceuticals | USD 7.2B | 7,200 | - | 12.9x | - | Confirmed 1 source | ||
| Microbiome Labs Control | 2021-01-06 | Novozymes | USD 125M Consideration | 125 | 3.1x | 6.0x | United States | Confirmed 1 source | ||
| Hu Master Holdings (Hu Products) Control (100%) | 2021-01-05 | Mondelēz International | Undisclosed Enterprise Value | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Every Man Jack Control | 2020-12-01 | The Carlyle Group | Undisclosed Undisclosed | Undisclosed | - | - | United States | Confirmed 1 source | ||
| Zicam Control | 2020-12-01 | Church & Dwight | USD 530M Consideration | 530 | 5.9x | 14.7x | United States | Confirmed 1 source | ||
| Smarty Pants Control | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 1 source | ||
| KIND North America Control | 2020-11-17 | Mars, Incorporated | USD 5.0B Enterprise Value | 5,000 | - | - | United States | Estimated 2 sources | ||
| Supreme Holdings, Inc. Control (100%) | 2020-11-09 | VF Corporation | USD 2.1B Enterprise Value | 2,100 | 4.2x | - | United States | Confirmed 4 sources | ||
| Valagro Control (10%) | 2020-10-06 | Syngenta Group | Undisclosed Undisclosed | Undisclosed | 3.4x | 17.5x | Global | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| Gymshark Capital Raise (21%) | 2020-08-14 | General Atlantic | GBP 1.0B Estimated Enterprise Value | 1,310 | 3.9x | - | United Kingdom | Confirmed 2 sources | ||
| Cremo Control | 2020-08-04 | Edgewell Personal Care | USD 235M Consideration | 235 | 4.1x | - | US | Confirmed 1 source | ||
| Thayers Natural Remedies Control | 2020-06-18 | L'Oréal | USD 400M Rumored Value | 400 | 7.3x | 13.3x | - | Estimated 1 source | ||
| Vital Proteins Control | 2020-06-10 | Nestlé Health Science | Undisclosed | Undisclosed | 4.3x | - | - | Confirmed 1 source | ||
| Charlotte Tilbury Control (73%) | 2020-06-04 | Puig | EUR 1.5B Enterprise Value | 1,713 | - | - | United Kingdom | Confirmed 5 sources | ||
| Golden Goose Control | 2020-02-12 | Permira | EUR 1.3B Estimated Enterprise Value | 1,419 | 5.0x | - | Italy | Estimated 7 sources | ||
| 2020-02-01 | ADM | Undisclosed | Undisclosed | - | - | Brazil | Unknown 1 source | |||
| Dermira Control | 2020-01-10 | Eli Lilly | USD 1.1B Transaction Value | 1,100 | - | - | - | Confirmed 2 sources | ||
| Tiffany & Co. Control (100%) | 2019-11-25 | LVMH Moët Hennessy Louis Vuitton SE | USD 16B Enterprise Value | 16,200 | 3.6x | 16.8x | United States | Confirmed 8 sources | ||
| King Kylie, LLC (Kylie beauty business) Control (51%) | 2019-11-18 | Coty Inc. | USD 1.2B Enterprise Value | 1,176 | 6.7x | 26.6x | United States | Confirmed 3 sources | ||
| Dr. Jart+ Control (67%) | 2019-11-18 | The Estée Lauder Companies | USD 1.7B Enterprise Value | 1,700 | 3.4x | - | South Korea | Estimated 2 sources | ||
| Drunk Elephant Holdings, LLC Control | 2019-10-08 | Shiseido Americas Corporation | USD 845M Enterprise Value | 845 | 8.5x | - | United States | Confirmed 4 sources | ||
| Quest Nutrition Control | 2019-08-22 | The Simply Good Foods Company | USD 1.0B Consideration | 1,000 | 2.9x | 17.4x | United States | Estimated 1 source | ||
| Filorga Control | 2019-07-11 | Colgate-Palmolive | EUR 1.5B Equity Purchase Price | 1,690 | 8.3x | - | France | Confirmed 4 sources |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.